Osteogenically-induced human dermal fibroblasts as a tool to regenerate bone

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Orthopedic Surgery

Background:

• Bone defects pose significant clinical challenges requiring reconstructive surgery.
• Osteogenic biomaterials offer a potential solution for bone regeneration.
• Current methods often involve invasive procedures with donor site morbidity.

Purpose of the Study:

• To investigate the efficacy of osteogenically-induced human dermal fibroblasts on microcarriers combined with platelet-rich plasma for bone defect repair.
• To evaluate the survival and osteogenic potential of these cells in a rat femoral defect model.

Main Methods:

• Six treatment groups were established for femoral defects in athymic rats, including controls, platelet-rich plasma, microcarriers, and various cell/microcarrier combinations.
• Femoral defects were assessed postoperatively using computed tomography (CT), histology, fluorescence in situ hybridization, and immunohistochemistry for osteogenic markers.
• Assessment occurred 4 weeks after transplantation.

Main Results:

• Radiographic analysis showed unhealed defects across all groups at 4 weeks.
• Defects treated with osteogenically-induced human dermal fibroblasts on microcarriers demonstrated dense cell clusters with abundant extracellular matrix.
• These specific clusters stained positive for osteocalcin and osteonectin, indicating osteogenic differentiation. Viable human cells were confirmed via fluorescence in situ hybridization.

Conclusions:

• Osteogenically-induced human dermal fibroblasts demonstrated survival and integration within the microcarrier scaffold in a bone defect environment.
• The formation of extracellular matrix and expression of bone-specific proteins suggest the development of bone-like structures.
• This approach shows promise for future bone tissue engineering strategies.